Literature DB >> 34676027

Psilocin Derivatives as Serotonergic Psychedelic Agents for the Treatment of CNS Disorders.

Robert B Kargbo1.   

Abstract

Entities:  

Year:  2021        PMID： 34676027      PMCID： PMC8521610          DOI： 10.1021/acsmedchemlett.1c00467

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.632


× No keyword cloud information.
  5 in total

Review 1.  Spine dynamics in the brain, mental disorders and artificial neural networks.

Authors:  Haruo Kasai; Noam E Ziv; Hitoshi Okazaki; Sho Yagishita; Taro Toyoizumi
Journal:  Nat Rev Neurosci       Date:  2021-05-28       Impact factor: 34.870

Review 2.  Hair cortisol concentrations in mental disorders: A systematic review.

Authors:  Elli Koumantarou Malisiova; Iraklis Mourikis; Christina Darviri; Nicolas C Nicolaides; Iannis M Zervas; Charalambos Papageorgiou; George P Chrousos
Journal:  Physiol Behav       Date:  2020-11-10

Review 3.  Clinical and biological predictors of psychedelic response in the treatment of psychiatric and addictive disorders: A systematic review.

Authors:  Bruno Romeo; Marianne Hermand; Amélie Pétillion; Laurent Karila; Amine Benyamina
Journal:  J Psychiatr Res       Date:  2021-03-07       Impact factor: 4.791

Review 4.  Predicting Reactions to Psychedelic Drugs: A Systematic Review of States and Traits Related to Acute Drug Effects.

Authors:  Jacob S Aday; Alan K Davis; Cayla M Mitzkovitz; Emily K Bloesch; Christopher C Davoli
Journal:  ACS Pharmacol Transl Sci       Date:  2021-03-05

Review 5.  Serotonin-related rodent models of early-life exposure relevant for neurodevelopmental vulnerability to psychiatric disorders.

Authors:  Tamara S Adjimann; Carla V Argañaraz; Mariano Soiza-Reilly
Journal:  Transl Psychiatry       Date:  2021-05-11       Impact factor: 6.222
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.